echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Deqi Pharmaceuticals and De Ruizhi Pharmaceutical Co., Ltd. to Promote the Research and Development of Small Molecule Drugs for Difficult Drug Targets

    Deqi Pharmaceuticals and De Ruizhi Pharmaceutical Co., Ltd. to Promote the Research and Development of Small Molecule Drugs for Difficult Drug Targets

    • Last Update: 2021-09-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On August 9, Deqi Pharmaceuticals and De Ruizhi Pharmaceuticals announced a cooperation to jointly promote the research and development of small molecule anti-tumor first-in-class drugs
    .


    Up to now, De Rui Zhi Yao has made a contribution to the development of a pre-clinical drug candidate of De Qi Pharmaceutical


    The cooperation in the difficult-to-find drug target project aims to improve the efficiency and success rate of current drug research and development, provide patients with breakthrough treatment plans, and meet more unmet medical needs


    Note: The original text has been deleted

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.